CLEDIBACT

This brand name is authorized in Nigeria.

Active ingredients

The drug CLEDIBACT contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7750	Tablet	CLEDIBACT 500MG TABLET TAB 500 mg 1 X 10	49 RNW-PP-240979 CLEDIBACT 500MG TABLET LEVOFLOXACIN 500MG LIST OF EXCIPIENTS. Microcrystalline cellulose (plain) BP Maize Starch BP. Sosium lauryl sulphate BP. Lactose BP. PVP K30(Providone) BP. Purified water BP. Sodium Starch Glycolate BP. Magnesium Stearate BP. Talcum BP. Colloidal Silicon Dioxide(Light)BP. Croscarmellose Sodium (Vivasole)BP. Titanium Dioxide BP. H.P.M.C.E 15 BP. Iso Propyl Alcohol BP. Methylene Chloride DCM BP. PFG 6000 BP. A4-7750 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 2/1/2022 PINNACLE HEALTH PHARMACEUTICAL & STORES LTD, 16/18, Nuru Oniwo Street, Aguda, Surulere, Lagos 8034707350 phppharma@yahoo.com GLOBELA PHARMA PVT. LTD., 357,G.I.D.C,SACHIN, DIST. SURAT-394230. GUJARAT STATE, INDIA, India	30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7750